March 7, 2026

Bharat Biotech’s Nasal Vaccine ‘Can Adapt’ To New COVID Strains, Regulatory Nod Awaited

Bharat Biotech's Nasal Vaccine 'Can Adapt' To New COVID Strains, Regulatory Nod Awaited

Bharat Biotech told News18 that the company’s COVID-19 vaccine platforms are enabled for “adaptation”. However, restarting production needs regulatory agency approvals.

More Stories

Oil Companies Urge Calm, Say India Has Adequate Petrol And Diesel Stock Amid West Asia War

Oil Companies Urge Calm, Say India Has Adequate Petrol And Diesel Stock Amid West Asia War

DK Shivakumar Proposes Legislative Council Seat For Contractors Amid Payment Dues Row

DK Shivakumar Proposes Legislative Council Seat For Contractors Amid Payment Dues Row

Declared Foreigner In Assam, Woman Gets Citizenship Under CAA

Declared Foreigner In Assam, Woman Gets Citizenship Under CAA

You may have missed

Oil Companies Urge Calm, Say India Has Adequate Petrol And Diesel Stock Amid West Asia War

Oil Companies Urge Calm, Say India Has Adequate Petrol And Diesel Stock Amid West Asia War

DK Shivakumar Proposes Legislative Council Seat For Contractors Amid Payment Dues Row

DK Shivakumar Proposes Legislative Council Seat For Contractors Amid Payment Dues Row

Declared Foreigner In Assam, Woman Gets Citizenship Under CAA

Declared Foreigner In Assam, Woman Gets Citizenship Under CAA

Loan Waiver Returns To Centre Stage In Maharashtra Budget Amid Focus On Farm Distress

Loan Waiver Returns To Centre Stage In Maharashtra Budget Amid Focus On Farm Distress

Discount Deleted: Has The West Asia War Ended India’s 'Cheap Russian Oil' Era?

Discount Deleted: Has The West Asia War Ended India’s ‘Cheap Russian Oil’ Era?